Ipamorelin is a synthetic peptide studied as a growth hormone secretagogue. In plain language, that means it can stimulate growth hormone release in experimental settings. Its research interest is associated with the ghrelin-receptor pathway, which differs from the growth hormone-releasing hormone pathway discussed for tesamorelin.
What question does ipamorelin research address?
The starting question is how a named compound influences growth hormone release under defined conditions. This is a mechanism-and-response question. It is separate from asking whether a material changes muscle mass, recovery, sleep or body composition in a particular population. Those outcomes need their own measurements and study design.
When searching for ipamorelin benefits, keep the outcome beside the claim. A hormone response is one type of finding; it is not a substitute for every other endpoint sometimes associated with the compound. This profile explains how to read the research, while the Ipamorelin product page supplies current catalogue information.
Two original studies to recognise
Raun and colleagues’ 1998 paper describes ipamorelin’s development and experimental growth hormone-releasing pharmacology. Its use of “selective” is tied to the measured responses and conditions in that work. It should not be expanded into an unrestricted claim that there can be no other effects in every setting.
A separate pharmacokinetic-pharmacodynamic study in human volunteers examines exposure and the growth hormone response. That kind of study answers a narrower question than a long-term trial with a body-composition or functional endpoint. Read the participants, observation period and outcome before deciding what the paper supports.
| Term | Plain-language meaning | What to check |
|---|---|---|
| Secretagogue | Stimulates secretion | Which response was measured? |
| Pharmacokinetics | How exposure changes with time | Which material and study population? |
| Pharmacodynamics | The response associated with exposure | Is the endpoint hormonal or clinical? |
| Selectivity | Preference or measured distinction in a defined system | Which other signals were actually tested? |
Ipamorelin versus tesamorelin
The shared growth hormone theme makes these names easy to group together. Their receptor routes differ: ipamorelin is associated with ghrelin-receptor signalling, whereas tesamorelin is a growth hormone-releasing hormone analogue. A shared downstream topic does not establish equivalent activity, evidence or package amounts.
The Ipamorelin versus Tesamorelin comparison explains the catalogue distinction. For a pathway overview, read growth hormone secretagogues explained. Compare the original studies themselves when the question concerns a specific outcome.
Reading a product listing separately from a paper
An original study is evidence about its reported material, model and conditions. It does not authenticate a vial supplied by another organisation. For a listing, check the compound identity, package amount and available exact-lot documentation independently. A nominal vial quantity is not a study outcome or an equivalent amount of a different peptide.
This is also why a product specification and a research profile serve different purposes. The specification describes the offered material. The profile helps you interpret a source. Use both, while keeping any unanswered analytical or lot questions visible.
Questions readers ask
Is ipamorelin supplied growth hormone?
No. A growth hormone secretagogue is a different category from the hormone itself.
Does selectivity prove a universal safety claim?
No. Interpret selectivity within the measurements and conditions of the cited research.
Where are current sizes and prices?
Use the live product listing rather than a research article. This profile does not store prices.
Sources and related reading
Raun et al.: original ipamorelin pharmacology; Human volunteer pharmacokinetic-pharmacodynamic study.
Read an evidence checklist · Understand a COA · Browse growth hormone research materials.
Read hormone research in context
An observed hormone response is a defined endpoint, rather than proof of every proposed downstream effect. Compare the measured outcomes and check the material identity before joining results from different studies.
Explore this topic further
Reading the evidence
Secretagogue pharmacology and experimental models
The early source concerns pharmacology in laboratory and animal models. Identify the receptor context and the measured hormonal response before interpreting a broader claim. A signalling result is not automatically a personal body-composition or performance outcome.

